Podcasts about rheumatic

Dr. Laura Plantinga joins us to discuss her recent work on the APPEAL study, which examines how lupus affects activities of daily living using patient-reported outcomes and validated measures such as IADLs, BADLs, SLAQ, and PROMIS. We explore her methodological approach, key findings, and implications for clinical practice—particularly how physicians can better support patients in managing functional limitations. Dr. Plantinga also shares insights on translating epidemiologic data into actionable strategies and maintaining scholarly productivity in academic medicine. 

In this episode, we explore a new approach to improving participation in lupus clinical trials by strengthening provider outreach and education. Our guest, Dr. Saira Sheikh of UNC Chapel Hill, discusses the TIMELY study, which focuses on involving healthcare providers and community health workers to better connect patients with trial opportunities. From roundtable discussions to changes in provider behavior, we highlight practical strategies that could improve how clinical trials are conducted. 

Guest: John Bridges, MD, MS For children with rheumatic diseases, early diagnosis, personalized care, and multidisciplinary collaboration are critical for optimal long-term management. Join Dr. John Bridges, Assistant Professor in the Division of Pediatric Rheumatology at the University of Alabama at Birmingham Heersink School of Medicine, as he explains how access, timing, and collaboration shape pediatric rheumatology care. Dr. Bridges presented on this topic at the 2025 Congress of Clinical Rheumatology East conference.

Guest: John Bridges, MD, MS For children with rheumatic diseases, early diagnosis, personalized care, and multidisciplinary collaboration are critical for optimal long-term management. Join Dr. John Bridges, Assistant Professor in the Division of Pediatric Rheumatology at the University of Alabama at Birmingham Heersink School of Medicine, as he explains how access, timing, and collaboration shape pediatric rheumatology care. Dr. Bridges presented on this topic at the 2025 Congress of Clinical Rheumatology East conference.

Guest: Laura Cappelli, MD, MHS,MS Patients who are receiving immunotherapy for cancer sometimes develop significant autoimmune complications, which can be fatal. Join Dr. Laura Cappelli, Associate Professor of Medicine and Oncology at the Johns Hopkins University School of Medicine, as she explains how multidisciplinary collaboration can help manage these rheumatic immune-related adverse events (irAEs). Dr. Cappelli also spoke about this topic at the 2025 Congress of Clinical Rheumatology East conference.

In this episode, we're joined by Dr. Atul Deodhar, a leading expert in the field of Axial Spondyloarthritis (AxSpA). Dr. Deodhar shares insights from his groundbreaking research on the pathophysiology, diagnosis, and management of AxSpA, particularly focusing on the efficacy and safety of IV secukinumab. We dive deep into his study, INVIGORATE-1, exploring the methods behind it, including the use of Interactive Response Technology, and the primary and secondary endpoints that shed light on this treatment's impact. We also discuss the latest data on patient preferences for subcutaneous versus intravenous immunomodulators and the implications of these findings. Tune in for an informative and engaging conversation that blends cutting-edge science with thoughtful reflections on patient care. 

"We must invest in long-term solutions. With this partnership, we're not just providing products – we're embedding healthy hygiene habits to protect these communities for generations.”

This week, we explore the genetics behind the production of antinuclear antibodies (ANA) in individuals without clinical autoimmune disease, using data from the All of Us registry. Our guest, Dr. Mehmet Hocaoglu shares insights into the significance of understanding ANA positivity and its potential genetic underpinnings, highlighting how large-scale genome-wide association studies (GWAS) can predict susceptibility to autoimmune conditions. We cover the study's methodology, the unique All of Us dataset, and the complexities of genetic analysis. Dr. Hocaoglu also discusses his personal journey in rheumatology research, offering advice for aspiring researchers, especially international medical graduates (IMGs).  

Host: Susanna Price Guest: Maya Buch Want to watch that extended interview? Go to: https://esc365.escardio.org/event/1801?resource=interview Disclaimer: ESC TV Today is supported by Bristol Myers Squibb. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsor. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Declarations of interests: Stephan Achenbach, Nicolle Kraenkel and Susanna Price have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Maya Buch has declared to have potential conflicts of interest to report: grant/research support paid to University of Manchester from Gilead and Galapagos; consultant and/or speaker with funds paid to University of Manchester for AbbVie, Boehringer Ingelheim, CESAS Medical, Eli Lilly, Galapagos, Gilead Sciences, Medistream and Pfizer Inc; member of the Speakers' Bureau for AbbVie with funds paid to University of Manchester. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

This episode covers: Cardiology This Week: A concise summary of recent studies AI and the future of the Electrocardiogram The heart in rheumatic disorders and autoimmune diseases Statistics Made Easy: Bayesian analysis Host: Susanna Price Guests: Carlos Aguiar, Paul Friedman, Maya Buch  Want to watch that episode? Go to: https://esc365.escardio.org/event/1801 Disclaimer: ESC TV Today is supported by Bristol Myers Squibb. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsor. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Declarations of interests: Stephan Achenbach, Antonio Greco, Nicolle Kraenkel and Susanna Price have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Maya Buch has declared to have potential conflicts of interest to report: grant/research support paid to University of Manchester from Gilead and Galapagos; consultant and/or speaker with funds paid to University of Manchester for AbbVie, Boehringer Ingelheim, CESAS Medical, Eli Lilly, Galapagos, Gilead Sciences, Medistream and Pfizer Inc; member of the Speakers' Bureau for AbbVie with funds paid to University of Manchester. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Paul Friedman has declared to have potential conflicts of interest to report: co-inventor of AI ECG algorithms. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Our immune system operates like a finely tuned symphony, yet many of us find ourselves out of harmony, vulnerable to persistent infections, autoimmune conditions, and chronic disease. Rather than merely suppressing symptoms, a Functional Medicine approach seeks to identify and address the underlying disruptions driving immune imbalance. Central to this dysfunction is compromised gut health, which undermines immune regulation, while mitochondrial impairment and chronic inflammation further erode the body's capacity for resilience and repair. By restoring balance at the root level, we can cultivate a more robust and adaptive immune system. In this episode, I discuss, along with Dr. Elroy Vojdani and Dr. Leonard Calabrese, how cleaning up our diets, improving gut health, removing toxins, and decreasing stress can do wonders for our immune systems. Dr. Elroy Vojdani is a pioneer in the field of functional medicine and research and is the founder of Regenera Medical, a concierge functional medicine practice in Los Angeles, California. He graduated from USC Keck School of Medicine, is a certified Institute for Functional Medicine Practitioner. Dr. Vojdani has conducted medical scientific research for decades with more than 25 publications in multiple peer-reviewed journals. He is also world-renowned for his research and development of state-of-the-art lab testing in the field of immunology. He recently authored a book entitled “When Food Bites Back” which discusses the role of food immune reactions in the development of autoimmune disease.  Dr. Leonard Calabrese, is an expert in immunology and rheumatology. In fact, he is a Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and Vice Chair of the Department of Rheumatic and Immunologic Diseases. Dr. Calabrese is the director of the RJ Fasenmyer Center for Clinical Immunology at the Cleveland Clinic and holds joint appointments in the Department of Infectious Diseases and the Wellness Institute. Dr. Calabrese has made significant contributions to science in the fields of chronic viral infections and autoimmunity and vascular inflammatory diseases of the brain. He has received numerous awards and honors for his contributions to the advancements of immunology and wellness. This episode is brought to you by BIOptimizers. Head to bioptimizers.com/hyman and use code HYMAN10 to save 10%. Full-length episodes can be found here: Boost Your Immunity with These Simple Steps How To Reset Your Immune System At A Cellular Level The Secrets to Creating a Healthy Immune System

In this episode, our host is joined by Dr. Peter Nigrovic, an expert in Macrophage Activation Syndrome (MAS). Dr. Nigrovic, delves into the complexities of MAS. The discussion covers the syndrome's history, diagnostic challenges, mechanisms of inflammation, and the latest treatment strategies, including cytokine blockade, JAK inhibitors, and chemotherapy options. Dr. Nigrovic also reflects on his unique career journey, offering valuable insights into combining clinical practice and research, while sharing his philosophy for a fulfilling life in medicine and science. This episode is a thorough exploration of MAS and provides practical advice for clinicians dealing with this complex syndrome. Macrophage Activation Syndrome 

Cheryl and Eileen stress the value of self-advocacy, working with a multidisciplinary team, and accessing reliable resources to navigate life with confidence and care.Episode at a glance:Mental Health and Support Groups: Cheryl and Eileen explore the transformative power of support groups, not only for attendees but also for those facilitating them. They discuss how mental health practices, like therapy and mindfulness, can supplement traditional care and provide emotional resilience.The Overlooked Impact of Sleep: Sleep disturbances, often dismissed as a symptom of rheumatic diseases, are addressed with actionable advice, including the need for sleep assessments to diagnose conditions like sleep apnea. Nutrition's Role in Managing Symptoms: Nutrition is examined as a key player in managing fatigue and overall well-being. Cheryl and Eileen discuss the benefits of a Mediterranean-style diet, the pitfalls of food shaming and misinformation, and how a positive, individualized approach to diet can support health without fostering food fearMedical disclaimer:All content found on Arthritis Life public channels was created for generalized informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment.Episode SponsorsRheum to THRIVE, an online course and support program Cheryl created to help people with rheumatic disease go from overwhelmed, confused and alone to confident, supported and connected. See all the details and join the program or waitlist now!Full Episode DetailsSee the full episode show notes including a transcript and video on the episode page here.

As our weekend here in Washington D.C. draws to an end, we turn our spotlight on an important and timely conversation from the "Sponsoring Women in Science" session. In this episode, we sit down with Dr. Elizabeth Volkmann and Dr. Carol Feghali-Bostwick to explore the challenges women face in advancing their careers in the sciences. Our guests share insights on how to address the barriers that often impede career development for women, discuss strategies for fostering support and mentorship, and highlight the importance of growing awareness around these critical issues.

Get ready for an electrifying episode of Convergence 2024! We're diving deep into the cutting-edge world of autoinflammatory diseases with renowned experts Drs. Grant Schulert and Arthur Kaser. Join us as they unravel the complexities of refractory and complicated systemic juvenile idiopathic arthritis (SJIA). Discover the revolutionary insights into SJIA at the single-cell level, explore the fascinating transcriptional diversity of normal and low-density granulocytes, and learn how groundbreaking approaches like UDON and SATAY-UDON are paving the way for novel disease programs. Don't miss this chance to fuel your passion for innovation in medicine—tune in and ignite your curiosity! 

This week we're joined by two leading experts in gout remissions, Dr. Nicola Dalbeth and Dr. Dansoa Tabi-Amponsah to explore the exciting advances in gout treatment, with a particular focus on Dual-Energy CT (DECT) imaging and its role in achieving gout remission. We dive into how DECT technology is transforming our ability to visualize urate crystals in joints, its implications for patient care, and the potential it holds for long-term gout management and remission. 

This is a re-release of Arthritis Life Podcast Episode 38, which pulled from a live webinar Cheryl presented in June 2021. To view the recording of the presentation which includes the slides, please go to bit.ly/flaretools (case sensitive). Episode at a glance:Updated intro from 2024: Cheryl introduces some additional resources for managing and preventing flare ups! Definition of a Flare-Up of a rheumatic disease (which includes ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis) What causes Flare-Ups, and why is it so important to discover our own unique flare triggers? Focus on Pain: tools to prevent pain and reduce existing painFocus on Fatigue: tools to prevent and reduce fatigue Focus on Stress: ways to decrease stress levels & cope with existing stress Focus on symptom tracking & Concluding Thoughts: how symptom tracking helps you discover your triggers Medical disclaimer: All content found on Arthritis Life public channels was created for generalized informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

In another installment in the ongoing Arthritis & Rheumatology immunology series, guest David S. Pisetsky, MD, PhD, author of Unique Interplay Between Antinuclear Antibodies and Nuclear Molecules in the Pathogenesis of Systemic Lupus Erythematosus, takes us on a deep dive into research in SLE on how the combination of ANAs and immunologically active DNA can create new structures that can promote inflammation throughout the body as well as drive organ inflammation and damage.

This week, the ACR is kicking off Rheumatic Disease Awareness Month (RDAM), and we've got Dr. Shah who introduces the concept of self-management, which can help improve the control of rheumatic disease beyond medication and empower our patients to take active roles in the management of them. Dr. Shah also spends time highlighting resources available for self-management and addresses how the ACR is advocating for improved healthcare polices and patient support and what you can do to take part in that process! 

As the dawn of the Ai revolution marches on, scientific research and clinical medicine are adopting new and more streamlined ways to investigate and serve our patients. Today, we look at how Ai-driven, large language models (LLMs) might aid our field's researchers in analyzing data from patient interviews. Dr. Bella Mehta, corresponding author of A Novel Approach for Mixed-Methods Research Using Large Language Models: A Report Using Patients' Perspectives on Barriers to Arthroplasty , joins us this week to give us her insights on this this quickly evolving technology and how it can be employed in both the research and clinical setting. 

Genetic conditions, inherited personality traits, brain chemistry...these are but a few of the well-known biological determinants of health and are but a small sample of factors that can determine how severe disease may affect a patient. But what role can social factors play in determining a patient's health? What of the ‘Social Determinants of Health (SDoH)'? Dr. Shivani Garg set out to identify these factors and understand how they play a role in determining the severity of symptoms in those with Lupus Nephritis (LN). What she discovered was that not only do these factors play a significant role, but each one added has a multiplicative effect on the patient's reported outcome! Dr. Garg is our guest today and her study, published in Arthritis Care & Rheumatology titled: Multiplicative Impact of Adverse Social Determinants of Health on Outcomes in Lupus Nephritis: A Meta-analysis and Systematic Review, will be the focus of our discussion. 

Advances in Rheumatic Disease, Improving Quality of Life | On Call with the Prairie Doc® | April 4, 2024 | Prairie Doc® host Dr. Kelly Evans-Hullinger, with guests Dr. Jennifer May from Rapid City Medical Center through zoom and Dr. Vivek Joseph from Sanford Rheumatology Clinic in Sioux Falls as they answer questions and discuss Rheumatic diseases.

Christine highlights the importance of lifestyle methods to manage chronic conditions including sleep hygiene, stress management, anti inflammatory nutrition, exercise and more. They discuss the importance of focusing on what brings joy and meaning to one's life while managing chronic illness.Overall, the conversation underscores the importance of a comprehensive approach to chronic pain management that addresses both the physical and emotional aspects of the patient's well-being.Episode at a glance:Chronic pain explained: Christine explains the 3 types of pain: nociceptive (as seen in active inflammation / tissue damage in RA), nociplastic (central sensitization, as in fibromyalgia) and neuropathic pain (nerve pain)Lifestyle: The best lifestyle adjustments to manage rheumatic disease, fibromyalgia and long covid: sleep, stress management, exercise, nutrition and moreMental health: The significance of addressing both the physical and emotional aspects of a patient's well-being in chronic pain management.Acceptance: Utilizing Acceptance and Commitment Therapy (ACT) as a valuable tool for managing chronic pain and navigating uncertainty.Joy: Focusing on finding joy and meaning in life while accepting the changes that come with chronic illness.Patient-provider relationship: Tips for building a trusting relationship with your health providerLong Covid and Fibromyalgia tips: Christine shares her best tips from her long covid and fibromyalgia clinicMedical disclaimer:All content found on Arthritis Life public channels was created for generalized informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment.Episode SponsorsRheum to THRIVE, an online course and support program Cheryl created to help people with rheumatic disease go from overwhelmed, confused and alone to confident, supported and connected. See all the details and join the program or waitlist now.For full details including a video and transcript:Go to the episode page on the Arthritis Life Website (episode page coming soon).

ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly. This episode covers: Cardiology This Week: A concise summary of recent studies Heart disease and sexual activity Rheumatic Heart Disease Snapshots Host: Perry Elliott Guests: Stephan Achenbach, Carlos Aguiar, Pernille Palm, Liesl Zuhlke Want to watch that episode? Go to: https://esc365.escardio.org/event/1145   Disclaimer This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.   Declarations of interests Stephan Achenbach, Nicolle Kraenkel, Pernille Palm and Liesl Zuhlke have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi, Novo Nordisk, Terumo, Medtronic. Perry Elliott has declared to have potential conflicts of interest to report: consultancies for Pfizer, BMS, Cytokinetics. Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer-Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.

None of us want bad things to happen; we went into this career to reduce the number or severity of badness for babies, children and young people after all. But how to tell if our actions are leading to more adverse effects… it's touched on in the podcast but read more here (https://adc.bmj.com/content/109/2/167.2) We're also thinking about balancing badness - the possible problems of NSAIDs alongside the problems from PPIs used trying to prevent them. There's a really good read and discussion of the challenges here (https://adc.bmj.com/content/109/2/167.1) We would love for you to be involved in Archi (https://adc.bmj.com/pages/authors/#archimedes) - just ask the questions that your patients are offering you - and tell us how you're finding the podcast offerings. Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832 

Dr. Tobit Steinmetz is our guest this week, author of the manuscript recently published in “Arthritis and Rheumatology” titled: "Association of Circulating Antibody-Secreting Cell Maturity with Disease Features in Primary Sjogren's Syndrome." Dr. Steinmetz and his team endeavored to better understand the hyperactivity observed among B cells, which play a major role in Primary Sjogren's Syndrome (SS). To do this, he and the team examined the quantity, maturity and inflammatory properties of Antibody Secreting Cells (ASCs) in the B cell effector branch, which became the focus of the study. Tune in to hear how this was done, what their observations and conclusions were plus, Dr. Steinmetz's insights for those looking to enter a postdoctoral position! 

This morning, Dave's struggling a little with a particular word, and he wanted to know, what words you can't pronounce! AND, Matt's found another use for AI...

Aquarius natives may have a moderate period. Gains from real estate are likely. You may enjoy positions of authority.  Unnecessary controversies and arguments may erupt in your personal life. Aquarius natives may suffer from lingering fear and anxiety. Travel related to work and profession are likely. The planets ensure that your finances will be good. Challenges may arise in your workplace dynamics. Businesses may become stable and ripe for expansion. Rheumatic problems and skin ailments are possible. Researchers and students of philosophy may see good progress in their academic lives.   If you would like to find out more about your chart or have a question about astrology you would love the answer to, please do connect with us at www.astroved.com Follow AstroVed on IG, Twitter, and FB @AstroVed 

Get Free Weekly Health Tips from Dr. HymanSign Up for Dr. Hyman's Weekly Longevity JournalGet Ad-free Episodes & Dr. Hyman+ Audio ExclusivesThe foundation of our health is a robust immune system that has a very important mechanism of cleaning out inflammatory cells. If this process is broken, the inflammatory cells can actually turn other functioning cells into inflammatory cells. Our daily life habits and exposures, such as sleep, stress management, diet, and toxins, affect key biological processes that impact our immune function. When our immune health is functioning properly, the rest of our body follows with less illness and disease.In today's episode, I talk with Dr. Elizabeth Boham and Dr. Leonard Calabrese about ways that we can support our immune systems to reduce the chance of illness and disease.Dr. Elizabeth Boham is a physician and nutritionist who practices Functional Medicine at The UltraWellness Center in Lenox, MA. Through her practice and lecturing she has helped thousands of people achieve their goals of optimum health and wellness. She witnesses the power of nutrition every day in her practice and is committed to training other physicians to utilize nutrition in healing.Dr. Leonard Calabrese is a Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and Vice Chair of the Department of Rheumatic and Immunologic Diseases. He is also the director of the RJ Fasenmyer Center for Clinical Immunology at the Cleveland Clinic and holds joint appointments in the Department of Infectious Diseases and the Wellness Institute.This episode is brought to you by Rupa University, AG1, and Paleovalley.Rupa University is hosting FREE classes and bootcamps for healthcare providers who want to learn more about Functional Medicine testing. Sign up at RupaUniversity.com.Get your daily serving of vitamins, minerals, adaptogens, and more with AG1. Head to DrinkAG1.com/Hyman and get 10 FREE travel packs with your first order.Paleovalley is giving listeners an additional 15% off their first order. Just visit Paleovalley.com/Hyman to save on clean snacks and supplements.Full-length episodes of these interviews can be found here:Dr. Mark HymanDr. Elizabeth BohamDr. Leonard Calabrese Hosted on Acast. See acast.com/privacy for more information.

Our next guest, Dr. Paul Monach, reviews “Complement”, focusing on its application in the clinical setting. In his work, Dr. Monach presents a typical case with a broad differential diagnosis, then provides an overview of the complement system along with clinical diseases with complement-driven mechanisms. Dr. Shanmugam reviews this manuscript published in Arthritis & Rheumatology plus an analysis of the laboratory tests. Later in the show, Dr. Monach gives us his insights on how he combines his clinical work with his translational work in immunology and acts Chief of Immunology at the VA in Boston, Massachusetts! 

End-stage renal disease is a dangerous reality for those who suffer from Lupus Nephritis (LN), despite improvements in immunosuppressive therapy in the last 20 years. Our next guest, Dr. Brad H Rovin, MD, FACP, FASN, is the first author of the manuscript “Kidney-Related Outcomes and Steroid-Sparing Effects in Patients with Active Lupus Nephritis Treated with Obinutuzumab: A Post Hoc Analysis of a Phase 2 Trial.” which was recently published in Arthritis & Rheumatology. This study was a post hoc analysis of the NOBILITY trial and was conducted to assess kidney-related outcomes in patients using Obinutuzumab. 

This week on ‘Journals', we turn our attention to a rare but challenging and heart-breaking complication of rheumatic disease, Congenital Heart Block. Sir Deryck and Lady Va Maughan Professor of Rheumatology and Director of the Division of Rheumatology at New York University School of Medicine, Dr. Jill Buyon joins us today to present her latest research “Prospective Evaluation of Anti-SSA/Ro Pregnancies Supports the Utility of High Titer Antibodies and Fetal Home Monitoring for the Detection of Fetal Atrioventricular Block.”. 

This week we welcome our next guest, Dr. John D. Pauling to ‘Journals'. Dr. Pauling is the senior author of the manuscript “Assessment of the Systemic Sclerosis-Associated Raynaud's Phenomenon Questionnaire: Item Bank and Short Form Development”, which endeavored to “develop, refine and score a novel patient-reported outcome instrument to assess the severity and impact of Raynaud's Phenomenon (RP) in Systemic Sclerosis (SSc)”. In this episode, we discuss the challenges associated with measuring one of the most common disease manifestations of scleroderma, Raynaud's, and how the Assessment of Systemic Sclerosis-Associated Raynaud's Phenomenon (ASRAP) questionnaire was harmonious in the paper's results and final conclusions. 

Melissa Christensen joins Amy Iler & Jack Sunday (sitting in for JJ Gordon) during the ima Doctors show. Melissa is a certified physician assistant, specializing in the treatment of rheumatic conditions including arthritis, tendinitis, lupus, gout and more. See omnystudio.com/listener for privacy information.

In the current episode of HeartBeat, Dr. Edoardo Zancanaro and special guest Prof. Maurizio Taramasso will present a case in which TMVR of the new generation can be used in rheumatic mitral stenosis. Tips and tricks, complications and current guidelines/articles will be discussed.

Today's guest is my rheumatologist Dr. Jerry Molitor. Dr. Molitor, acting chief of Rheumatology at the VA Hospital-Minneapolis  and is an Associate Professor of Medicine in the Division of Rheumatic and Autoimmune Diseases at the University of Minnesota Medical School. We had a wonderful conversation and started our discussion on the CONQUER Registry (an acronym for Collaborative National Quality and Efficacy Registry), which is a National Scleroderma Patient Registry. We also discussed the Clinical Study Consortium and ideas on how to get involved with trial studies. 

Rheumatic fever rates are on the rise, and have now returned to pre-Covid levels. Despite other high income nations reducing or near eliminating rheumatic fever, New Zealand is still struggling to control the disease. Rheumatic fever is preventable, and Dr Rawiri McKree Jansen says the country has an obligation to eliminate the disease, which disproportionately affects Maori and Pasifika people. He says New Zealand must address over-crowding in homes, and how the health system reaches the most vulnerable. Susie Ferguson speaks to Dr Rawiri McKree Jansen, the chief medical officer at Te Aka Whai Ora, the Maori Health Authority.

Join Dr. Szot and his guests to discuss reproductive health in patients with rheumatic and musculoskeletal diseases. Joseph Szot, MD Associate Dean for Continuing and Integrated Medical Education Clinical Professor of Internal Medicine University of Iowa Carver College of Medicine Brittany Bettendorf, MD Associate Professor of Internal Medicine University of Iowa Carver College of Medicine Emily B. Walsh, PharmD Clinical Pharmacy Specialist in the Adult Rheumatology Clinic University of Iowa Hospitals and Clinics References/Resources:  2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Disease. https://onlinelibrary.wiley.com/doi/epdf/10.1002/art.41191 Briggs Drugs in Pregnancy and Lactation, 12th edition – text that can be physically purchased or found in Lexicomp, an online drug reference Drugs & Lactation Database LactMed® - https://www.ncbi.nlm.nih.gov/books/NBK501922/ https://mothertobaby.org/ US Medical Eligibility Criteria for Contraceptive Use: https://www.cdc.gov/reproductivehealth/contraception/mmwr/mec/summary.html Financial Disclosures:  Dr. Joe Szot, his guests and the members of the planning committee for Rounding@IOWA have no relevant financial relationships to disclose. CME Credit Available:  https://uiowa.cloud-cme.com/course/courseoverview?P=0&EID=56695  Physicians: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Pharmacists: The University of Iowa Carver College of Medicine designates this knowledge-based activity for a maximum of 0.5 ACPE contact hours.  Credit will be uploaded to the NABP CPE Monitor within 60 days after the activity completion.  Pharmacists must complete the online evaluation and provide their NABP ID and DOB (MMDD) to receive credit.  Other Health Care Providers: A certificate of completion will be available after successful completion of the course. (It is the responsibility of licensees to determine if this continuing education activity meets the requirements of their professional licensure board.) Date Recorded: 05/02/2023  

Lemierre's Syndrome? Sacrébleu! This is a nasty, rare complication of pharyngitis, but it's much more common than Rheumatic fever. Let's nail the diagnosis and treatment on this nasty F. necrophorum infection. Want to experience the greatest in board studying? Check out our interactive question bank podcast- the FIRST of its kind here: emrapidbombs.supercast.com. Cite this podcast as: Briggs, Blake. Episode 176. Lemierre's syndrome: Mon Dieu! May 15th, 2023. https://www.emboardbombs.com/podcasts/176-lemierres-syndrome-mon-dieu. Accessed [date]

Approximately 54 million adults and 300,000 children in the United States have rheumatic diseases. Today, I am excited to learn from Dr. Celine Lee about the top 3 lifestyle tips that you need to know while dealing with rheumatic diseases (Chron's disease, gout, arthritis, etc) Dr. Lee is a board-certified dermatologist who graduated from Korea University Medical School in South Korea in 2002. She completed her dermatology residency at the National Medical Center of South Korea and worked as a dermatologist in South Korea for several years. After coming to the United States in 2011, she completed her second residency in Internal Medicine at Albert Einstein Medical Center in Philadelphia. She was accepted into UCLA Rheumatology Fellowship and completed her fellowship in 2016. Dr. Lee also studied lifestyle medicine and obtained board certification in that field. She currently works at her own clinic, Lotus Rheumatology, and Wellness Clinic, where she approaches her patients' health as a whole, utilizing her expertise in four different specialties to discover the root cause of their medical problems and provide solutions to those underlying causes rather than just treating individual symptoms. Contact Dr. Lee https://www.facebook.com/LotusRheumatology https://www.youtube.com/@lotusrheumatology6705 --- Send in a voice message: https://podcasters.spotify.com/pod/show/urcaringdocs/message

Melissa Christiansen, a Physician Assistant at ima Healthcare specializing in treating rheumatic conditions including arthritis, tendinitis, lupus, gout and many others, joins Amy & JJ to take listeners questions. See omnystudio.com/listener for privacy information.

On this episode of My Lupus Living Room, Adrienne fills in for Suzanne and sits down with Dr Emily Littlejohn, DO, MPH from the Cleveland Clinic. She may be our most accomplished guest yet, and while she did complete her Rheumatology Fellowship at that school up north, she's made up for it in spades by helping countless lupus patients across Ohio. We've put her resume below: Emily Littlejohn completed her undergraduate education at Georgetown University, where she received a B.S in Human Science. After college she moved to Boston where she received a M.P.H in Epidemiology from Boston University of Public Health. She then attended Medical School at Western University College of Osteopathic Medicine of the Pacific (COMP) where she was awarded a research fellowship in the Department of Biotechnology. She went on to complete her Internal Medicine Residency at Loyola University Medical Center in Chicago, IL and Rheumatology Fellowship at the University of Michigan where she worked closely with lupus patients and became interested in this complex and elusive disease. She joined the medical staff in the Department of Rheumatic and Immunologic Diseases at Cleveland Clinic in 2017 and holds a faculty position of Clinical Assistant Professor in the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. She directs the Cleveland Clinic Lupus Cohort (CCLC), a longitudinal bio repository that banks blood and urine of lupus patients and is co- director of the Lupus Clinic.

“Rheumatology For All” is an organization with a global mission: To increase access to rheumatology care in under-resourced regions. They aim to create self-sustaining rheumatology training programs by funding the education of local physicians to become rheumatologists and provide educational programs for local physicians. Much of the organization's work is done in developing nations throughout Africa. Today, we have founding member and member of the board of directors, Dr. Michele Meltzer as our guest, to discuss their mission, how it began, where “Rheumatology For All” is going, and how you can get involved in the great need to expand rheumatic care to these under-served countries. 

 Paul Allan Offit is an American pediatrician specializing in infectious diseases, vaccines, immunology, and virology. He is the co-inventor of a rotavirus vaccine. Offit is the Maurice R. Hilleman Professor of Vaccinology, professor of pediatrics at the Perelman School of Medicine at the University of Pennsylvania, former chief of the Division of Infectious Diseases (1992–2014), and the director of the Vaccine Education Center at The Children's Hospital of Philadelphia. He has been a member of the Centers for Disease Control (CDC) Advisory Committee on Immunization Practices Dr. Offit is a board member of Every Child By Two and a Founding Board Member of the Autism Science Foundation (ASF).[Dr. Offit shares his stories as a child in Baltimore with Polio and Dr. Markowitz one of three researchers who studied Group A Strep ( Drs. Denis and Wannamaker ).  With the help of the "quiet heroes" polio and Rheumatic Heart Disease are no longer a disease of children or pediatrics. But many children gave the ultimate sacrifice when they did not receive the vaccine or penicillin in the clinical trials and died from the disease. Such is the nature of medical innovation.   All Business. No Boundaries.Welcome to All Business. No Boundaries, a collection of supply chain stories by DHL...Listen on: Apple Podcasts Spotify The Brave MarketerBrands are navigating the new Web3 and marketing in the metaverseListen on: Apple Podcasts SpotifyPlease subscribe to our podcast on apple or amazon and give us a great review. You can make suggestions for guests and topics on our website below. Thanks for listening. Follow us on social media YouTube, Instagram, WebPage The Pediatric Lounge - A Podcast taking you behind the door of the Physician's Lounge to get a deeper insight into what docs are talking about today, from the clinically profound to the wonderfully routine...and everything in between. The conversations are not intended as medical advice and the opinions expressed are solely those of the host and guest.

In this episode we will talk about different rheumatological conditions that can mask as musculoskeletal pain and how to recognize them. Our guest is Jack March, a physiotherapist specialising in rheumatology who provides CPD courses on the recognition, investigation and management of rheumatological conditions. We will shine a light on imaging and medical tests for different conditions and cover differences between genders. At last, we will discuss how patients with rheumatism are best treated, talk about precautions during exercise and how to positively influence their prognosis. So make sure to listen to the whole episode! Enjoy!   Content 00:00 - 00:58 Introduction 00:58 - 02:18 What is Rheumatism? 02:18 - 03:47 Rheumatological diseases to know 03:47 - 05:28 When to think it's Rheumatic 05:28 - 08:16 Screening for Rheumatoid Disorders 08:16 - 11:46 How Rheumatoid Inflammation is different 11:46 - 15:32 What are the Signs & Symptoms 15:32 - 17:04 How helpful is Imaging? 17:04 - 18:55 Difference in males vs. females 18:55 - 22:10 Testing for Rheumatoid Disorders 22:10 - 27:11 Referral to Specialist Management 27:11 - 35:45 What Physios can do in RD 35:45 - 37:55 Jack's Closing Thoughts 37:55 - 38:54 Outro   Bonus Material To view and download the bonus content such as transcripts of this episode become a Physiotutors Member. All episodes and bonus content can be found here   Follow our Podcast on: Spotify | Apple Podcasts

In this episode, we review the high-yield topic of Rheumatic Heart Disease from the Cardiovascular section. Follow Medbullets on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial Twitter: www.twitter.com/medbullets

Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com.  New regulatory decisions about JAK inhibitors and why do women with rheumatic diseases have unfair outcomes?

It is so easy to get caught in the minutiae of our daily work. And, sometimes it is incredibly helpful to zoom out and take a big picture look at the incredible changes we have seen in healthcare over the past decades. The journal article we are looking at this week gives us a bird's-eye view of the past, present, and future of managing rheumatic and musculoskeletal (MSK) diseases. In the article you'll find the same trends that we see in occupational therapy-specific research: a focus on self-management, patient reported outcome measures and patient centeredness. In looking to the future, technology is going to further enable all of these trends. After the articles orients us to the advances in MSK care, we will be joined by Winnie Tsui, OTL, CHT, MBA, who works as a product manager on the frontiers of technology in this area.  Winnie will help us understand the exciting technology that is ushering the future of care—and the role OT has the potential to play in this exciting new reality.In order to earn credit for this course, you must take the test within the OT Potential Club.You can find more details on this course here:https://otpotential.com/ceu-podcast-courses/rheumatic-musculoskeletal-occupational-therapyHere's the primary research we are discussing:Burmester, G., Bijlsma, J., Cutolo, M. et al. Managing rheumatic and musculoskeletal diseases — past, present and future. Nat Rev Rheumatol 13, 443–448 (2017). Support the show

CardioNerds (Amit Goyal and Dan Ambinder) join Dr. Radi Zinoviev, Dr. Josh Cohen, and Dr. Tiffany Dong (CardioNerds Ambassador) from the Cleveland Clinic for a day on Edgewater beach. They discuss the following case of the evaluation and management of prosthetic tricuspid valve stenosis in a patient with a history of Ebstein Anomaly. The expert commentary and review (ECPR) is provided by Dr. Jay Ramchand, staff cardiologist with expertise in multimodality cardiovascular imaging at the Cleveland Clinic. Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. This episode is made possible with support from the 3rd Annual Going Back to the Heart of Cardiology (A MedscapeLIVE Conference). Join Dr. Robert Harrington and Dr. Fatima Rodriguez December 3-5, 2022 at the Hilton La Jolla Torrey Pines in San Diego, CA for this innovative event. Network with your colleagues, attend engaging presentations by renowned cardiologists, participate in conference activities, and earn up to 10.25 CME/CE credits. You don't want to miss the keynote presentation by health and fitness expert Bob Harper (NBC's The Biggest Loser). Earn up to 3.0 additional CME/CE credits by adding this year's NEW Virtual Interventional Session: Cath Lab Challenge to your conference registration. Register today with code CARDIONERDS for 30% OFF your registration. Click here for more information. Jump to: Case media - Case teaching - References CardioNerds Case Reports PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Case Media CXR ECG TTE RHC Final TTE TTE 1 TTE 2 TTE 3 Follow up TTE 1 Follow up TTE 2 Episode Schematics & Teaching Pearls - Tricuspid Valve Stenosis Tricuspid stenosis is uncommon ( 60cm.Structural findings that support the presence of severe tricuspid stenosis include a moderately dilated RA and a dilated IVC, though these are not specific.Right heart catheterization hemodynamics that support tricuspid stenosis include a high right atrial pressure and gradual “y” descent.Bioprosthetic tricuspid valves are generally favored over mechanical valves due to risk of thrombosis and longevity of these valves in the tricuspid position. Notes - Tricuspid Valve Stenosis What are causes of tricuspid stenosis? Causes of tricuspid stenosis can be divided into congenital and acquired causes. Congenital causes include tricuspid atresia or stenosis. Acquired causes include rheumatic heart disease, carcinoid syndrome, endocarditis, prior radiation, or fibrosis from endomyocardial procedures or placement of electrical leads. Rheumatic heart disease is the most common cause of tricuspid stenosis and is usually associated with mitral valvulopathy. What are the symptoms and physical exam findings of tricuspid stenosis? Findings revolve around right sided congestion or heart failure symptoms such as peripheral edema, abdominal distension with ascites, hepatomegaly, and jugular venous distension. When examining the jugular vein, you may see prominent a-waves and an almost absent or slow y descent reflective of delayed emptying of the right atrium (in the absence of tricuspid regurgitation). The murmur of tricuspid stenosis includes an opening snap and low diastolic murmur at the left lower sternal border with inspiratory accentuation. Patients may also report fatigue due to decreased cardiac output from obstruction.

In this week's episode, we discuss the "ACR's 2022 Guideline Summary for Vaccinations in Patients with Rheumatic and Musculoskeletal Diseases" with lead author Dr. Anne Bass, Attending Physician in the Division of Rheumatology at Hospital for Special Surgery and a Professor of Clinical Medicine at Weill Cornell Medicine. During our conversation we consider the importance of guidelines for vaccines, the impact certain drugs like rituximab and methotrexate have on vaccinations, cover some vaccine highlights within the guidelines, how these guidelines can aid in navigation with insurance companies and much, much more.